Professor of Politics
King’s College London
Bush House (North East Wing)
London WC2B 4BG
Room number: 8.15 Bush House (North East Wing)
Telephone: +44 (0)20 7848 2300
Professor Brian Salter is Deputy Head of Department and responsible for the development and implementation of the Department's strategy. He is the Director of the Global Biopolitics Research Centre.
His research deals with the political sociology of power in the domains of science, health and education focusing in particular on the role of ideology and markets in the control of knowledge. In biomedicine he explores the global politics driving the governance response to new health technologies, the impact of the emerging economies and the role of bioethics in that process. In the case of ageing, he applies a Gramscian framework to an analysis of how health consumers have established a market based counter-hegemony to the ideology of decline.
Most recently, he has explored the role of British university intellectuals in the ideological conflict surrounding Brexit, the underlying cultural foundations of that conflict, and the capacity of the British state to respond and adapt to the demands it generates.
An experienced flight instructor and flight examiner, Brian is the only professor in the UK to have flown a World War II Spitfire and force landed a civilian aircraft at Williams Air Force Base in the United States.
- Public Policy Doctoral Programme
Main Research Interests
- Global politics of innovation and biomedicine
- Hegemony, markets and intellectuals
- Brexit and the British state
Recent Funded Research
ESRC Rising Powers Programme (2010-11) ‘Strategies of governance in global biomedical innovation: the impact of China and India’. (with Dr Alex Faulkner)
EU FP7 (2009-12).PEGASUS ‘Genetically modified animals. Science, utility and society.’ Workpackage on policy development and implementation.(with Nuria Vazquez Salat)
EU FP7 (2008-11).REMEDiE ‘Regenerative medicine in Europe: emerging needs and challenges in a global context’. Workpackage on state strategies.(with Dr Stuart Hogarth)
Wellcome Trust (2009-14). ‘From animal to human? Regulating inter-species embryos in a global ethical context’. Project within the London and Brighton Translational Ethics Centre.(with Dr Alison Harvey)
ESRC Stem Cell Programme (2005-08) ‘The global politics of human embryonic stem cell science’. (with Professor Catherine Waldby and Professor Herbert Gottweis)
Rising Powers II: State strategies of governance in global biomedical innovation: The impact of China and India (with Dr Alex Faulkner)
Nine books and over 100 articles. Recent publications include:
Salter B (2018). When intellectuals fail? Brexit and hegemonic challenge. Competition and Change. [available online]
Salter B and Salter C (2018). 'The politics of ageing: health consumers, markets and hegemonic challenge'. Sociology of Health and Illness. 40(6):1069-1086
Salter B and Salter C (2017). Controlling new knowledge: genomic science, governance and the politics of bioinformatics. Social Studies of Science. 47(2): 263-287. Available online at: http://journals.sagepub.com/doi/pdf/10.1177/0306312716681210
Salter B, Zhou Y and Datta S (2016): Governing new global health-care markets: the case of stem cell treatments, New Political Economy. Published online 1st July.
Salter B, Zhou Y, Datta S and Salter C (2016). Bioinformatics and the politics of innovation in the life sciences: science and the state in the United Kingdom, China and India. Science, Technology and Human Values. 1-34.
Salter B, Filippakou, Tapper T (2016). Expanding the English medical schools: The politics of knowledge control. London Review of Education. 14(1): 23-32
Salter, B., Zhou, Y., & Datta, S. (2015). Hegemony in the marketplace of biomedical innovation: Consumer demand and stem cell science. Social Science & Medicine 131: 156-163.
Salter B and Harvey B (2014). Creating problems in the governance of science: bioethics and human/animal chimeras. Science and Public Policy. 41(5): 685-696.
Salter B and Salter C (2013). Bioethical ambition, political opportunity and the European governance of patenting: the case of human embryonic stem cell science. Social Science and Medicine. 98: 286-292.
Harvey A and Salter B (2012). Governing the moral economy: animal engineering, ethics and the liberal government of science. Social Science and Medicine. 75: 193-199.
Harvey A and Salter B (2012). Anticipatory governance: bioethical expertise for human/animal chimeras. Science as Culture. 21(3): 291-313.
Vàzquez-Salat N, Salter B, Smets G, Houdebine LM (forthcoming 2012). The current state of GMO governance: Are we ready for GM animals? Biotechnology Advances.
Filippakou O, Salter B and Tapper E (2012). Higher Education as a System: The English Experience. Higher Education Quarterly. 66(1): 106–122
Salter B and Waldby C (2011). Biopolitics in China: an introduction. East Asia Science and Technology: An International Journal. 5(3): 287-90. [Special Issue]
Salter B and Faulkner A (2011). State strategies of governance in biomedical innovation: aligning conceptual approaches for understanding ‘Rising Powers’ in the global context. Globalisation and Health. 7(3).
Salter B (2011). Biomedical innovation and the geopolitics of patenting: China and the struggle for future territory. East Asian Science and Technology: An International Journal. 5:1–18
Jones M and Salter B (2010). Proceeding Carefully: assisted human reproduction policy in Canada. Public Understanding of Science. 19(4): 420-434.
Hogarth S and Salter B (2010). Regenerative medicine in Europe: global competition and innovation governance. Regenerative Medicine. 5(6): 971-85.
Filippakou O, Salter B and Tapper T (2010).Compliance, Resistance and Seduction: Reflections on 20 Years of the Funding Council Model of Governance in English Higher Education. Higher Education. 60(5): 543-557
Salter B (2010). Governing innovation in the biomedicine knowledge economy: stem cell science in the USA. Science and Public Policy 37(2): 87-100.
Salter B, Gottweis H, Waldby C (2009). The global politics of human embryonic stem cell science: regenerative medicine in transition. Basingstoke: Palgrave.
Salter B (2009). China, globalisation and health biotechnology innovation: venture capital and the adaptive state. East Asian Science and Technology: an International Journal. 3(4): 401-423.
Salter B and Qiu, R. (2009) Bioethical governance and basic stem cell science: China and the global biomedicine economy. Science & Public Policy. 36(1): 47-59.
Salter B (2009). State strategies and the global knowledge economy: the geopolitics of regenerative medicine. Geopolitics. 14: 1-31.
Fenton L and Salter B (2009). Competition and compromise in negotiating the new governance of medical performance: the clinical governance and revalidation policies in the UK. Health, Economics, Policy and Law. 4: 283-203.
Salter B (2008) Governing stem cell science in China and India: emerging economies and the global politics of innovation. New Genetics and Society. 27(2): 145-49.
Waldby C and Salter B (2008). Global Governance in Human Embryonic Stem Cell Science: Standardisation and Bioethics in Research and Patenting. Studies in Ethics Law and Technology. 2(1): 1-23.
Salter B and Harvey O (2008). Stem cell innovation in the USA: the benefits of the minimal state. Regenerative Medicine. 3(4): 597-610.
Salter B, Cooper M, Dickins A, Cardo V (2007). Stem cell science in India: emerging economies and the politics of globalisation. Regenerative Medicine. 2(1): 75-89.
Salter B (2007) ‘The global politics of human embryonic stem cell science’. Global Governance. 13: 277-98.
Salter B (2007). Bioethics and the global moral economy: the cultural politics of human embryonic stem cell science. Science, Technology and Human Values. 32(5): 1-28.
Greenaway J, Salter B, Hart S (2007). How policy networks can damage democratic health: a case study in the government of governance. Public Administration. 85(3): 1-22.
Salter B (2007). Patenting, morality and human embryonic stem cell science: bioethics and cultural politics in Europe. Regenerative Medicine. 2(3): 301-11.
Salter, B (2007) Bioethics, politics and the moral economy of human embryonic stem cell science: the case of the European Union’s Sixth Framework Programme. New Genetics and Society. 26(3).
Salter B and Jones M (2006) ‘Change in the policy community of human genetics: a pragmatic approach to open governance’. Policy and Politics. 34(2): 347-66.
Salter B, Cooper M, Dickins A (2006). ‘China and the global stem cell bioeconomy:an emerging political strategy?’. Regenerative Medicine. 1(5): 671-83.
Salter B (2006). Governing UK medical performance: a struggle for policy dominance. Health Policy. October.
Salter B and Jones M (2005) ‘Biobanks and bioethics: the politics of legitimation’. Journal of European Public Policy. 12 (4): 710-732
Salter B (2004), The New Politics of Medicine, Basingstoke, Palgrave
Greenaway J, Salter B, Hart S (2004). ‘The evolution of a “meta-policy”: the case of the Private Finance Initiative and the Health Sector’. Journal of British and International Politics. 6(4): 507-26.
Salter B and Jones M (2003) ‘The governance of human genetics: policy discourse and constructions of public trust’ New Genetics and Society. 22(1): 21-42.
Salter B (2003) ‘Patients and doctors: reformulating the UK policy community?’ Social Science and Medicine. 57: 927-36.
Frewer, L.J and Salter, B. (2003). The changing governance of biotechnology: The politics of public trust in the agri-food sector. Applied Biotechnology, Food Science and Policy, 1 (4) 199-211.
Salter B (2002) ‘Medical regulation: new politics and old power structures’ Politics vol 22(2): 59-67.
Salter B and Frewer LJ (2002) ‘Public attitudes, scientific advice and the politics of regulatory policy: the case of BSE’ Science and Public Policy 29(2): 137-45.
Salter B and Jones M (2002) ‘Human genetic technologies: European governance and the politics of bioethics’ Nature Reviews Genetics. vol 3(10): 808-14.